Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

BACKGROUND--There is uncertainty regarding the use of monotherapy or combination therapy with beta 2 agonists and anticholinergic drugs in patients with chronic obstructive pulmonary disease (COPD). The measurement of forced expiratory volume in one second (FEV1) or relaxed vital capacity (RVC) in t...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Thorax
Principais autores:	Newnham, D. M., Dhillon, D. P., Winter, J. H., Jackson, C. M., Clark, R. A., Lipworth, B. J.
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 1993
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC464905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8296260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.48.11.1151
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!